Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Carleton S. Ellis"'
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
There are very few therapeutic options to treat patients with locally advanced or metastatic Urothelial Cancer (UC). Enfortumab vedotin (EV) was recently approved by the FDA and has become a new therapeutic option for patients previously managed with
Externí odkaz:
https://doaj.org/article/e78c1ead756244ecbf7f8bc745251f2a
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
The clinical management of metastatic urothelial carcinoma has significantly evolved with the emergence of monoclonal antibodies and antibody-drug conjugates (ADCs). Enfortumab vedotin (EV) was granted approval by the FDA in 2021 for patients with lo
Externí odkaz:
https://doaj.org/article/806d3f41a0b94793a7f51fdec3362849
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
The treatment landscape of metastatic castration-resistant prostate cancer (mCRPC) has dramatically improved over the last decade; however, patients with visceral metastases are still faced with poor outcomes. Phosphatase and tensin homolog (PTEN) lo
Externí odkaz:
https://doaj.org/article/89365cccbea1498aaf1c5081afca1cc9
Autor:
Minsig Choi, Megan M. Harper, Prakash K. Pandalai, Sherif R. Z. Abdel-Misih, Reema A. Patel, Carleton S. Ellis, Ellen Reusch, Jeri Reynolds, Caterina Vacchi-Suzzi, Jinha M. Park, Georgios V. Georgakis, Joseph Kim
Publikováno v:
Annals of Surgical Oncology. 30:804-813
Autor:
Hannah G. McDonald, Reema A. Patel, Carleton S. Ellis, Sepideh Gholami, Mautin Barry-Hundeyin, Prakash K. Pandalai, Joseph Kim, Michael J. Cavnar
Publikováno v:
Surgery.
Autor:
Zin W. Myint, William H. St. Clair, Stephen E. Strup, Donglin Yan, Ning Li, Derek B. Allison, Laurie E. McLouth, Carleton S. Ellis, Peng Wang, Andrew C. James, Patrick J. Hensley, Danielle E. Otto, Susanne M. Arnold, Robert S. DiPaola, Jill M. Kolesar
Publikováno v:
Cancers; Volume 15; Issue 9; Pages: 2505
Purpose: Cannabinoids (CBD) have anti-tumor activity against prostate cancer (PCa). Preclinical studies have demonstrated a significant decrease in prostate specific antigen (PSA) protein expression and reduced tumor growth in xenografts of LNCaP and
Autor:
Minsig, Choi, Megan M, Harper, Prakash K, Pandalai, Sherif R Z, Abdel-Misih, Reema A, Patel, Carleton S, Ellis, Ellen, Reusch, Jeri, Reynolds, Caterina, Vacchi-Suzzi, Jinha M, Park, Georgios V, Georgakis, Joseph, Kim
Publikováno v:
Annals of Surgical Oncology. 30:814-815
Publikováno v:
Journal of child and adolescent psychopharmacology. 29(9)